Hofseth Biocare ASA plans a subsequent offering of up to 16,666,666 new shares for eligible shareholders, as announced on October 27, 2025. Trading of the company’s shares will exclude the right to participate in the offering. Advokatfirmaet CLP DA is the legal advisor to Hofseth Biocare ASA. For more information, contact CEO Jon Olav Ødegård at +47 936 32 966 or [email protected]. The offering is not available in certain jurisdictions, including the United States, and is subject to specific legal restrictions. Forward-looking statements in the announcement highlight potential risks and uncertainties. This announcement does not serve as investment advice and is for informational purposes only.

Read more at GlobeNewswire: Ex. Subsequent Offering Today